Ligand validation:4N39

UDP: URIDINE-5'-DIPHOSPHATE

UDP is a Ligand Of Interest in 4N39 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4N39_UDP_A_1201	96%	37%	0.08	0.987	0.91	1.53	-	5	0	0	100%	1
4GYW_UDP_C_1101	100%	37%	0.037	0.988	1.03	1.45	2	4	0	0	100%	1
4GZ3_UDP_A_1101	99%	35%	0.045	0.983	1.08	1.47	1	5	0	0	100%	1
3PE4_UDP_A_1212	94%	36%	0.079	0.976	1.03	1.49	2	4	0	0	100%	1
5LWV_UDP_A_1201	93%	27%	0.088	0.983	1.04	1.87	2	11	0	0	100%	1
4CDR_UDP_E_1001	87%	24%	0.111	0.982	1.03	2.05	1	7	0	0	100%	1
8X3Q_UDP_C_401	100%	3%	0.015	0.998	3.32	2.69	13	13	0	0	100%	1
8X3U_UDP_B_401	100%	3%	0.012	0.999	3.31	2.68	13	13	2	0	100%	1
8VH8_UDP_C_704	100%	62%	0.032	0.995	0.55	0.9	-	1	0	0	100%	1
2IV7_UDP_A_1372	100%	40%	0.035	0.984	0.85	1.49	-	4	0	0	100%	1
4PHR_UDP_A_301	100%	42%	0.042	0.989	0.84	1.41	-	4	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.